Yanina Grant-Huerta, Chief Accounting Officer at Atara Biotherapeutics, Inc. (ATRA), sold 1,804 shares at $13.19 ($24K) on 2025-11-17, disclosed to the SEC on 2025-11-19.
Open-market sale of $24k ATRA by Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.19 | 74 | $976 | 4.1% |
| 2 | $13.19 | 85 | $1K | 4.7% |
| 3 | $13.19 | 1,645 | $22K | 91.2% |
| Total | $13.19 avg | 1,804 | $24K | 100% |
| Filing → |
| ATRA | SELL | 2025-08-20 | $21K | — | Filing → |
| ATRA | SELL | 2025-05-20 | $15K | — | Filing → |